Cargando…
Zeolites as Carriers of Antitumor Ribonuclease Binase
Natural and synthetic zeolites have many applications in biomedicine and nutrition. Due to its properties, zeolites can absorb therapeutically active proteins and release them under physiological conditions. In this study we tested the clinoptilolite, chabazite, and natrolite ability to be loaded by...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509225/ https://www.ncbi.nlm.nih.gov/pubmed/31130858 http://dx.doi.org/10.3389/fphar.2019.00442 |
_version_ | 1783417205979873280 |
---|---|
author | Khojaewa, Vera Lopatin, Oleg Zelenikhin, Pavel Ilinskaya, Olga |
author_facet | Khojaewa, Vera Lopatin, Oleg Zelenikhin, Pavel Ilinskaya, Olga |
author_sort | Khojaewa, Vera |
collection | PubMed |
description | Natural and synthetic zeolites have many applications in biomedicine and nutrition. Due to its properties, zeolites can absorb therapeutically active proteins and release them under physiological conditions. In this study we tested the clinoptilolite, chabazite, and natrolite ability to be loaded by antitumor ribonuclease binase and the cytotoxicity of the obtained complexes. We found the optimal conditions for binase loading into zeolites and established the dynamic of its release. Cytotoxic effects of zeolite-binase complexes toward colorectal cancer Caco2 cells were characterized after 24 and 48 h of incubation with cells using MTT-test. Zeolites were toxic by itselfs and reduced cells viability by 30% (clinoptilolite), 40% (chabazite), and 70% (natrolite) after 48 h of incubation. Binase complexes with clinoptilolite as well as chabazite always demonstrated enhanced toxicity (up to 57 and 60% for clinoptilolite and chabazite, respectively) in comparison with binase and zeolites separately. Our results contribute to the perspective development of binase-based complexes for therapy of colorectal cancer for or the treatment of malignant skin neoplasms where the complexes can be used in pasty form. |
format | Online Article Text |
id | pubmed-6509225 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65092252019-05-24 Zeolites as Carriers of Antitumor Ribonuclease Binase Khojaewa, Vera Lopatin, Oleg Zelenikhin, Pavel Ilinskaya, Olga Front Pharmacol Pharmacology Natural and synthetic zeolites have many applications in biomedicine and nutrition. Due to its properties, zeolites can absorb therapeutically active proteins and release them under physiological conditions. In this study we tested the clinoptilolite, chabazite, and natrolite ability to be loaded by antitumor ribonuclease binase and the cytotoxicity of the obtained complexes. We found the optimal conditions for binase loading into zeolites and established the dynamic of its release. Cytotoxic effects of zeolite-binase complexes toward colorectal cancer Caco2 cells were characterized after 24 and 48 h of incubation with cells using MTT-test. Zeolites were toxic by itselfs and reduced cells viability by 30% (clinoptilolite), 40% (chabazite), and 70% (natrolite) after 48 h of incubation. Binase complexes with clinoptilolite as well as chabazite always demonstrated enhanced toxicity (up to 57 and 60% for clinoptilolite and chabazite, respectively) in comparison with binase and zeolites separately. Our results contribute to the perspective development of binase-based complexes for therapy of colorectal cancer for or the treatment of malignant skin neoplasms where the complexes can be used in pasty form. Frontiers Media S.A. 2019-05-03 /pmc/articles/PMC6509225/ /pubmed/31130858 http://dx.doi.org/10.3389/fphar.2019.00442 Text en Copyright © 2019 Khojaewa, Lopatin, Zelenikhin and Ilinskaya. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Khojaewa, Vera Lopatin, Oleg Zelenikhin, Pavel Ilinskaya, Olga Zeolites as Carriers of Antitumor Ribonuclease Binase |
title | Zeolites as Carriers of Antitumor Ribonuclease Binase |
title_full | Zeolites as Carriers of Antitumor Ribonuclease Binase |
title_fullStr | Zeolites as Carriers of Antitumor Ribonuclease Binase |
title_full_unstemmed | Zeolites as Carriers of Antitumor Ribonuclease Binase |
title_short | Zeolites as Carriers of Antitumor Ribonuclease Binase |
title_sort | zeolites as carriers of antitumor ribonuclease binase |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509225/ https://www.ncbi.nlm.nih.gov/pubmed/31130858 http://dx.doi.org/10.3389/fphar.2019.00442 |
work_keys_str_mv | AT khojaewavera zeolitesascarriersofantitumorribonucleasebinase AT lopatinoleg zeolitesascarriersofantitumorribonucleasebinase AT zelenikhinpavel zeolitesascarriersofantitumorribonucleasebinase AT ilinskayaolga zeolitesascarriersofantitumorribonucleasebinase |